Pure Global

Angiography System - Vietnam Registration 2402711ĐKLH/BYT-HTTB

Access comprehensive regulatory information for Angiography System in Vietnam's medical device market through Pure Global AI's free database. This Risk Class TTBYT Loại C medical device is registered under number 2402711ĐKLH/BYT-HTTB and manufactured by Siemens Healthineers. The authorized representative in Vietnam is CÔNG TY TNHH SIEMENS HEALTHCARE.

This page provides complete technical specifications, regulatory compliance details, 5 companies making similar products including Philips Medical Systems Nederland B.V., Siemens Healthcare GmbH, and 5 recent registrations in the same category. Pure Global AI offers free access to 300,000+ Vietnamese medical device registrations, helping global MedTech companies navigate Vietnam MOH regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
300,000+ Devices
5 Competitors
5 Recent Registrations
2402711ĐKLH/BYT-HTTB
Registration Details
Vietnam MOH Registration: 2402711ĐKLH/BYT-HTTB
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Device Details

Angiography System
VN: Hệ thống chụp mạch
Risk Class TTBYT Loại C

Registration Details

2402711ĐKLH/BYT-HTTB

17001215/ĐKLH-BYT-TB-CT

Theo theo phụ lục

Theo phụ lục

Company Information

Theo theo phụ lục

Siemens Healthineers

Technical Details

Artis Q/zeego/Q.zen, as a dedicated angiography system for creating X-ray fluoroscopic images, is designed to provide diagnostic images, interventional and minimally invasive treatment images, and to minimize the radiation exposure to the patient. The product is used to guide the imaging process in non-invasive, vascular, cardiovascular, neurovascular, endovascular and surgical procedures. The Artis Q/zeego/Q.zen system also offers software options that allow the reconstruction of two-dimensional angiography images into 3D image formats, as well as various diagnostic, planning, guidance and treatment monitoring support options.

Dates and Status

Oct 02, 2024